EN
Home/Start here/It's for a family member
Reading path3 guides, in order

Someone in my family might need a GLP-1. How do I help?

For anyone helping a parent, partner or relative decide, and then supporting them through it.

GLP Guidebook teamUpdated 12 Oct 20264 min read15 sourcesWritten from published sources
The short answer

Read the basics together, talk without blame, and go to the appointment with them if they'd like you there. Weight is driven by genes and surroundings, not just willpower. GLP-1 medicines are usually long-term. Provincial plans cover semaglutide for type 2 diabetes with conditions, but none covers these medicines for weight management, so it's private insurance or paying for every pen. Older parents need extra care with fluids, low sugar and muscle.

Read this page first. It covers how to bring it up, who pays, what to watch for in an older parent and how to prepare for the appointment. At the end, three guides take you further, in order.
On this page
  1. Talking without shame
  2. Who pays, and for how long
  3. An older parent
  4. Going to the appointment
  5. The risks, in brief
  6. What to read next
  7. Sources

How do I bring it up without shame?

Talk about health and how they feel, not how they look. And drop the blame.

A group of international experts agreed that obesity is not a choice.1 It comes mainly from genes and the world around us.1

Shame also backfires. People who fear being judged are less likely to seek care.1

  • Avoid words like "lazy" or "greedy", even as a joke. The experts' pledge rejects them.1
  • Start from what they care about: energy, knees, sugar levels, keeping up with grandchildren.
  • Ask "How can I help?" rather than telling them what to do.
  • Ask before you share their health with other relatives.

Who pays, and for how long?

Plan for a cost that may run for years, not weeks.

Most of the weight usually returns after stopping. In a follow-up of the main semaglutide 2.4 mg (Wegovy) trial, people regained about two-thirds of it within a year of stopping.2 So agree early who pays, and for how long.

Who pays depends on why they take it. Checked 12 Oct 2026.

  • For weight management: no provincial plan covers Wegovy, Zepbound or Saxenda.3 Only a small number of private insurers do, usually with forms and rules.5
  • For type 2 diabetes: provincial plans cover semaglutide with conditions, usually after metformin. In Ontario, for example, people 65 and over are covered by the Ontario Drug Benefit program, which lists semaglutide for type 2 diabetes as Limited Use.4 See the type 2 diabetes path.

If you pay yourself, for a sense of scale: Wegovy was $388.64 a pen (4 weekly doses, about a month) at any dose in Canada's Drug Agency's 2025 review.7 Zepbound's reported list price is $300 per 4 weeks at the 2.5 and 5 mg doses and $420 at 7.5 and 10 mg (from 29 Dec 2025).8 Pharmacy prices can differ. Prescription medicines can count toward the Medical Expense Tax Credit.6 The cost calculator works out a year's total, and Guide 6 has the official prices.

What should I watch for in an older parent?

Older adults do take these medicines. Watch three things closely: fluids, low sugar and muscle.

In the main Ozempic trials, 744 people, about 1 in 4 of those taking part, were 65 or older. No overall differences in safety or effect were seen between older and younger people.10

  • Fluids. Vomiting or diarrhea can dry them out and harm the kidneys.10 Check they're drinking enough, especially when they're unwell.
  • Low sugar. If they take insulin or a sulfonylurea (an older diabetes tablet such as gliclazide), the risk of a hypo (low blood sugar) goes up.10 Learn the signs: dizziness, sweating, shakiness, confusion.10
  • Muscle. Part of the weight lost is lean mass (everything that isn't fat, including muscle), and older age raises the risk of muscle loss (sarcopenia).11 Ask the doctor about protein and safe exercise.
  • Other tablets. These medicines slow the stomach, which can change how other tablets are absorbed.10 Keep a full list of everything they take.

Should I go to the appointment with them?

If they'd like you there, yes. A second pair of ears helps, and you'll both hear the same advice.

Know which route you're on. All GLP-1 medicines are prescription drugs in Canada. Their family doctor or nurse practitioner is usually the first step. A virtual visit must meet the same standard of care as an in-person one.13 Health Canada says to fill prescriptions only at a licensed pharmacy and check the DIN on the box.12

Take with you

  • A list of all their medicines, including herbal remedies and anything bought online
  • Recent results: A1C, kidney tests, blood pressure readings
  • "Which medicine and dose, and why this one?"
  • "Which side effects should we call you about?"
  • "How will we know it's working, and when do we review?"
  • "Will their provincial plan or insurance cover it? What will each month cost?"
If they have diabetesShould they consider it?Cost calculator

What to read next, in order

These three guides go deeper. Each one ends with a link to the next, so you can read them one after another.

  1. 1Weight and health: what BMI and waist numbers meanGuide 1 of 9UnderstandUnderstand their numbers first: BMI, waist size, and the lower numbers for Asian adults.
  2. 2Should I consider a GLP-1? And when not toGuide 4 of 9DecideWho prescribers may consider for a GLP-1, and the reasons not to, including age and kidneys.
  3. 3Side effects and risksGuide 5 of 9DecideKnow the side effects together, so you both know which ones need help fast.
Was this page easy to understand?

Sources

  1. Rubino F et al. Joint international consensus statement for ending stigma of obesity. Nature Medicine, 2020;26:485–497. Statements 6.2 and 10.3, and Box 1. Declared interests: 15 of 36 authors declare ties to Novo Nordisk and 2 to Eli Lilly; Novo Nordisk was one of the sponsors of the meeting's travel costs (paper's own declaration). Full text
  2. Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022;24(8):1553–1564. 327 people followed for a year after stopping. DOI
  3. BC PharmaCare. Drug coverage decision: semaglutide (Wegovy), 18 December 2025 ("Non-benefit"; pCPA negotiations concluded without agreement). Status of public plans checked 12 October 2026. gov.bc.ca (PDF)
  4. Government of Ontario. Get coverage for prescription drugs (Ontario Drug Benefit: people 65 and older and other groups); Ontario Drug Benefit Formulary (semaglutide Limited Use for type 2 diabetes). Checked 12 October 2026. ontario.ca · formulary
  5. Global News. Novo Nordisk to cut Ozempic price as generics arrive ("only a small number of private insurers cover the use of the drugs for weight management"). 26 May 2026. globalnews.ca
  6. Canada Revenue Agency. Details of medical expenses (prescription drugs recorded by a pharmacist). Checked 12 October 2026. canada.ca
  7. Canada's Drug Agency (CDA-AMC). Semaglutide (Wegovy) SR0841 pharmacoeconomic review ("The unit cost is $388.64 per pen… the cost of pens is the same for all doses"). canjhealthtechnol.ca
  8. Benefits and Pensions Monitor (reporting The Globe and Mail). Eli Lilly cuts Canadian obesity drug prices ($300 per 4-week supply for 2.5 and 5 mg; $420 for 7.5 and 10 mg, from 29 December 2025). 19 December 2025. benefitsandpensionsmonitor.com
  9. Pedersen SD et al. Canadian Adult Obesity Clinical Practice Guideline: Pharmacotherapy for Obesity Management in Adults, 2025 update. Obesity Canada, Version 3, 11 August 2025 (pregnancy notes). obesitycanada.ca (PDF)
  10. Novo Nordisk. Ozempic (semaglutide) injection, US prescribing information and Medication Guide, revised May 2026. Sections 4, 5.3, 5.5, 5.6, 7.2, 8.5. (US label.) PDF
  11. Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes, Obesity and Metabolism, 2024;26(Suppl 4):16–27. DOI
  12. Health Canada. Thinking about buying GLP-1 drugs like Ozempic or Mounjaro? Beware of fake or unauthorized products (advisory RA-81518), updated 21 January 2026. recalls-rappels.canada.ca
  13. College of Physicians and Surgeons of Ontario. Virtual Care policy, updated June 2022. cpso.on.ca
  14. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM, 2021;384:989–1002. 1,961 adults without diabetes, 68 weeks. DOI
  15. Novo Nordisk. Wegovy (semaglutide) US prescribing information, revised June 2026. Sections 1, 2.2, 5.2, 5.3, 5.5, 8.3, 17. (US label.) PDF

Last checked 12 Oct 2026 · Next review due Jan 2027

How this page was made. Written by the GLP Guidebook team from the sources above: drug labels, published trials, the Canadian obesity guideline, Canada's Drug Agency, provincial plans and Health Canada pages. It's general information, not medical advice. Talk to a family doctor, nurse practitioner or pharmacist before starting, stopping or changing any medicine. In an emergency, call 911. How we write